Absolute Return Capital’s Haemonetics HAE Stock Holding History

Absolute Return Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-16,460	Closed	-$581K	–	749
2014 Q2	$581K	Buy	+16,460	New	+$550K	0.01%	806

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Absolute Return Capital's HAE Position: Q3 2014 in Review

Absolute Return Capital sold out of Haemonetics (HAE) in Q3 2014, closing a stake of 16,460 shares — an estimated $581K sold.

Absolute Return Capital first reported a position in HAE in Q2 2014 and held it in 1 quarter. The position peaked at $581K in Q2 2014. 170 funds tracked by Wall St. Rank hold HAE as of Q3 2014.

Absolute Return Capital reported no remaining Haemonetics position as of Q3 2014 after selling out during the quarter.
Absolute Return Capital sold 16,460 Haemonetics shares in Q3 2014, an estimated $581K.
Absolute Return Capital first reported a position in Haemonetics in Q2 2014 and held it in 1 quarter.
Absolute Return Capital's Haemonetics position peaked at $581K in Q2 2014.
170 funds tracked by Wall St. Rank held Haemonetics as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.